Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Journal of Health Economics
|
July 2, 2013
Abortion before & after Roe
Ted Joyce, Ruoding Tan, Yuxiu Zhang
Cancers
|
March 11, 2023
Patient Preferences for Unresectable Hepatocellular Carcinoma Treatments: A Discrete-Choice Experiment
Daneng Li, Ruoding Tan, Sairy Hernandez, et al.
Frontiers in Public Health
|
June 10, 2022
Assessing Real-World Racial Differences Among Patients With Metastatic Triple-Negative Breast Cancer in US Community Practices
Ruoding Tan, Lourenia Cassoli, Ying Yan, et al.
Future Oncology (London, England)
|
April 19, 2024
Race/ethnicity and socioeconomic position in emergency department utilization in patients with hepatocellular carcinoma
Daniel Lin, Ruoding Tan, Christie Teigland, et al.
Pharmacoeconomics
|
February 7, 2014
Treatment, monitoring, and economic outcomes of venous thromboembolism among hospitalized patients in China
Eric Q Wu, Jipan Xie, Chun Wu, et al.
Journal of Hepatocellular Carcinoma
|
July 25, 2024
Why Liver Cancer Hits Home: Bridging Healthcare Disparities in the Asian American and Pacific Islander Community
Daneng Li, Spencer Cheng, Andrea Wilson Woods, et al.
Cancers
|
October 26, 2024
Overall Survival in Real-World Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab Versus Sorafenib or Lenvatinib as First-Line Therapy: Findings from the National Veterans Health Administration Database
David E Kaplan, Ruoding Tan, Cheryl Xiang, et al.
Annals of Surgical Oncology
|
December 2, 2024
Prognostic Significance of Recurrence and Timing of Recurrence on Survival Among Patients with Early-Stage Hepatocellular Carcinoma in U.S. Clinical Practice
Shishir K Maithel, Rongrong Wang, Joanna Harton, et al.
Annals of Surgical Oncology
|
December 8, 2024
ASO Visual Abstract: Prognostic Significance of Recurrence and Timing of Recurrence on Survival Among Patients with Early-Stage Hepatocellular Carcinoma in US Clinical Practice
Shishir K Maithel, Rongrong Wang, Joanna Harton, et al.
The Oncologist
|
March 11, 2022
Impact of Immune Checkpoint Inhibitors on COVID-19 Severity in Patients with Cancer
Ruoding Tan, Cindy Yun, Arpamas Seetasith, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Journal of Health Economics
|
July 2, 2013
Abortion before & after Roe
Ted Joyce, Ruoding Tan, Yuxiu Zhang
Cancers
|
March 11, 2023
Patient Preferences for Unresectable Hepatocellular Carcinoma Treatments: A Discrete-Choice Experiment
Daneng Li, Ruoding Tan, Sairy Hernandez, et al.
Frontiers in Public Health
|
June 10, 2022
Assessing Real-World Racial Differences Among Patients With Metastatic Triple-Negative Breast Cancer in US Community Practices
Ruoding Tan, Lourenia Cassoli, Ying Yan, et al.
Future Oncology (London, England)
|
April 19, 2024
Race/ethnicity and socioeconomic position in emergency department utilization in patients with hepatocellular carcinoma
Daniel Lin, Ruoding Tan, Christie Teigland, et al.
Pharmacoeconomics
|
February 7, 2014
Treatment, monitoring, and economic outcomes of venous thromboembolism among hospitalized patients in China
Eric Q Wu, Jipan Xie, Chun Wu, et al.
Journal of Hepatocellular Carcinoma
|
July 25, 2024
Why Liver Cancer Hits Home: Bridging Healthcare Disparities in the Asian American and Pacific Islander Community
Daneng Li, Spencer Cheng, Andrea Wilson Woods, et al.
Cancers
|
October 26, 2024
Overall Survival in Real-World Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab Versus Sorafenib or Lenvatinib as First-Line Therapy: Findings from the National Veterans Health Administration Database
David E Kaplan, Ruoding Tan, Cheryl Xiang, et al.
Annals of Surgical Oncology
|
December 2, 2024
Prognostic Significance of Recurrence and Timing of Recurrence on Survival Among Patients with Early-Stage Hepatocellular Carcinoma in U.S. Clinical Practice
Shishir K Maithel, Rongrong Wang, Joanna Harton, et al.
Annals of Surgical Oncology
|
December 8, 2024
ASO Visual Abstract: Prognostic Significance of Recurrence and Timing of Recurrence on Survival Among Patients with Early-Stage Hepatocellular Carcinoma in US Clinical Practice
Shishir K Maithel, Rongrong Wang, Joanna Harton, et al.
The Oncologist
|
March 11, 2022
Impact of Immune Checkpoint Inhibitors on COVID-19 Severity in Patients with Cancer
Ruoding Tan, Cindy Yun, Arpamas Seetasith, et al.
Page
of 2